2017 is an extraordinary year for the pharmaceutical industry. The “Green Channel†speeds up drug review and approval; the MAH pilot adds vitality to the research and development of pharmaceutical companies; various policies have inserted “wings†for the pharmaceutical industry... as an industry The main body and the achievements of pharmaceutical companies determine the development status and future trends of the industry to a certain extent. Although the performance report of pharmaceutical companies in the third quarter has not yet been fully disclosed, from the results of the interim report, the overall performance is impressive, and nearly 80% of enterprises are happy.
Excellent results are inseparable from policy support and high market demand. It is also inseparable from the positive innovation and research and development of pharmaceutical companies, strict control of production quality and sincere service to customers. In order to show products, technologies, services and brands to our customers more intuitively and effectively, the exhibition has become the channel of choice for many companies. In November 2017, there will be three major exhibitions in the pharmaceutical industry. The following authors will give you a comprehensive introduction to the highlights of these three major exhibitions.
The 54th National Pharmaceutical Machinery Exhibition
Since its inception in 1991, the Pharmaceutical Machinery Exhibition has been successfully held for 53 sessions. At present, it covers 8 major categories of raw material medicine machinery and equipment, pharmaceutical packaging machines, preparation machinery, drug testing equipment, medicinal crushing machinery, decoction pieces machinery, pharmaceutical water equipment, and other pharmaceutical machinery and equipment. In the course of 26 years of development, the pharmaceutical machine exhibition has grown into a professional and large-scale exhibition in China's pharmaceutical machinery industry.
Judging from the holdings of recent exhibitions, there are over 1,000 exhibitors, with over 7,000 booths and 10,000 exhibition units. Taking the 52nd National Pharmaceutical Machinery Exhibition as an example, the author knows that there are more than 1,300 exhibitors, the total area of ​​the exhibition is more than 130,000 square meters, the total number of booths is more than 7,300, and the flow of people is about 100,000. Among them, there are more than 200 international exhibitors from Europe, the United States, South Korea, Japan, and India.
(Professional audience company nature distribution)
In the 53rd National Pharmaceutical Machinery Exhibition, the audience gathered 24 countries and regions. Among them, 75.3% are domestic-funded enterprises, 14.6% are joint ventures, and the rest are foreign-funded enterprises. Among these professional visitors, 47% belong to pharmaceutical production, 26% to pharmaceutical machinery manufacturing, and 18% to biopharmaceuticals. In addition, the top three types of equipment that professional viewers are most concerned about are 61% of preparation equipment, 46% of drug testing equipment, and 32% of raw material medicine equipment.
(Professional audience belongs to the industry)
As can be seen from the above data, the scale of the pharmaceutical machine exhibition is constantly expanding, and the professionalism and participation of the industry audience is increasing. In addition, we can also see that, unlike the initial stage of the exhibition, the exhibitors and audiences of the Pharmaceutical Machinery Exhibition are becoming more and more international. The number of overseas visitors and exhibitors has increased in recent years, which also reflects the pharmaceutical exhibition from the side. The degree of internationalization has increased.
With the rapid development of the industry, increasingly fierce competition, and the acceleration of upgrading of pharmaceutical equipment, the exhibition of the pharmaceutical machine exhibition not only provides a platform for product display and technical exchange for the majority of pharmaceutical companies, but also builds good business opportunities for manufacturers and buyers. bridge. Every spring and autumn, the drug machine show will meet with industry professionals. The exhibition is not only an important platform for leading companies to consolidate their brands, stabilize their customer base, but also a stage for many emerging companies to show their strength. In addition, the new product display in each exhibition seems to have become the vane of the future trend of the industry.
Of course, the Pharmaceutical Machinery Exhibition is not only a new product show, but also a professional training session. These trainings invited experts from the pharmaceutical engineering and equipment companies in the industry to teach on hot topics and interact with the audience. Taking the specific needs of the relevant fields of equipment management in the pharmaceutical industry as the starting point, combined with the discussion of the advanced concepts of the international pharmaceutical industry, and strive to introduce advanced concepts and technologies, promote the overall level of the pharmaceutical industry and international technical exchanges.
CHINA-PHARM 2017 Pharmaceutical Industry Exhibition
CHINA-PHARM was established in 1996. Unlike the National Pharmaceutical Machinery Exhibition, CHINA-PHARM covers not only pharmaceutical equipment, but also accessories and packaging materials, cosmetics, analytical testing and industry-related services, outsourcing, consulting, and associations. , media and information agencies, etc. After more than 20 years of growth, CHINA-PHARM has become a platform for the dissemination of well-known exhibitions and advanced pharmaceutical concepts with important influence in the international pharmaceutical field.
"Interpretation of policy authority, integration of international exchanges, and cutting-edge technology display" is a distinctive feature of CHINA-PHARM. At the same time, CHINA-PHARM has also played an active role in cooperating with the implementation of China's pharmaceutical GMP, the upgrading of pharmaceutical equipment, the introduction of foreign advanced pharmaceutical equipment and technology, and the integration of China's pharmaceutical equipment companies with international standards.
In recent years, the scale of CHINA-PHARM has also broken through. The author was informed that the 19th CHINA-PHARM exhibition covers an area of ​​30,000 square meters. A total of 431 well-known Chinese and foreign companies from 22 countries and regions have spent a lot of time at this medical ceremony. In the 20th exhibition, the number of international exhibitors was over 57%. Among them, international pavilions such as Germany and the United Kingdom also appeared in CHINA-PHARM.
(CHINA-PHARM Proportion of Domestic and Foreign Exhibitors)
It can be seen that CHINA-PHARM international exhibitors have exceeded half of the total, showing the extent of their influence overseas. For local pharmaceutical companies interested in entering the international market, CHINA-PHARM is an ideal platform for technical exchanges and corporate cooperation with foreign companies.
In addition, the author learned from CHINA-PHARM that this exhibition will focus on drug safety supervision as a core element of service. All along, drug safety issues have affected all parties in the society. The state and local governments are also guarding the people's "security on the tongue" through policies and regulations, regulatory actions, and propaganda activities. Since last year, some pharmaceutical companies have received complaints from customers about risk prevention and control, and they are looking for a platform for smoother communication with regulators and pharmaceutical companies. Pharmaceutical companies are also thinking about how to clarify the potential impact of different process equipment selection on the development, verification, sterility assurance, and risk control of production processes.
As a window of private international exchanges between the State Food and Drug Administration, CHINA-PHARM will hold technical exchanges every time to provide in-depth solutions for pharmaceutical companies. CHINA-PHARM will also play its role as an interactive communication platform between the regulatory authorities, pharmaceutical companies and pharmaceutical companies, and carry out a series of special technical exchange activities to answer questions for pharmaceutical companies and pharmaceutical companies, thereby promoting the entire pharmaceutical industry. Industrial science develops healthily.
79th API China
API China is the oldest exhibition in China's pharmaceutical industry. Founded in 1968, its China International Pharmaceutical Equipment Exhibition (Sinophex) is held twice a year. It also holds raw material exhibitions, pharmaceutical packaging exhibitions and accessories exhibitions. Compared with China Pharm and China Pharm, API China is characterized by comprehensive industry coverage, wide range of exhibits and rich supporting activities. It has become a one-stop shopping for tens of thousands of pharmaceutical and health products manufacturers at home and abroad. The high-efficiency platform meets the needs of all types of exhibitors and visitors, providing a good channel for domestic and foreign people to fully understand the development trend of China's pharmaceutical and health care products industry, get to know friends in the industry and discover new business opportunities.
API China not only strives to make the exhibition platform scientific and rational, but also pays more attention to humanization, while humanization focuses on the following three aspects:
First, we will continue to innovate based on exhibitors and audiences. API China has built a big health industry online platform, Lichun, through the "Internet + Exhibition" approach, combined with strong offline resources. Lichun can not only match the buyer's needs and match the buyer, but also send an appointment invitation. As long as both parties confirm the meeting time, they can communicate and communicate without barriers. Meeting the demands of more and more buyers for fast and accurate search for quality product suppliers has also made it easier for suppliers to find high-end buyers.
(API China Lichun Platform)
Second, starting from the details, form a unique service unique to API China. China is the world's largest exporter of APIs and enjoys an important position in the international market. API China has also attracted the attention of global API buyers. In order to help our pharmaceutical factories to successfully connect with international buyers, API China provides international buyers with a full-service butler service from "off the plane to the plane", attracting more than 20 countries from the United States, Germany, the United Kingdom, Japan, etc. More than 3,000 overseas visitors to visit and purchase
Third, use powerful resources to establish a promotion channel network for users. API China aims to combine important websites, WeChat, email and dozens of media partners to promote important exhibition information, industry news and latest product information for exhibitors and visitors.
In addition to the above three aspects, the conference forum organized by API China is also a major feature. For the above-mentioned exhibition, for example, according to Mr. Wu Xuetao, the director of Sinopharm Reed Pharmaceuticals, the organizer of the exhibition, a total of 23 conferences and forums were held during the last exhibition, and more than 80 reputable industry experts and leaders were invited to give guidance to enterprises. The number of participants reached a new high.
Mr. Wu Xuetao also revealed to the author that one of the highlights of the 79th API China Conference is that Sinopharm Reed will jointly create the “First China Smart Pharmaceutical 2025 Summit†in conjunction with the China Pharmaceutical and Pharmaceutical Industry Association's Intelligent Pharmaceutical Equipment Committee. The summit will gather in China Pharmaceuticals. The person in charge of the enterprise, the person in charge of the pharmaceutical engineering and technology, the person in charge of the pharmaceutical factory and the person in charge of production, experts from government, colleges and universities, scientific research institutes, and intelligent pharmaceutical systems and equipment suppliers will jointly improve the automation and informationization of China's pharmaceutical equipment. The level of intelligence is to explore the path of transformation and upgrading in line with the actual situation of China's pharmaceutical industry, so that smart manufacturing benefits every Chinese pharmaceutical company!
Conclusion:
2017 is coming to an end, and November is the key month for major companies to sprint. The three major events will gather in November, which will undoubtedly bring more business opportunities to the pharmaceutical industry and make the industry develop a new spark.
It is understood that these three major exhibitions have their own advantages and highlights, but their ultimate goal is to make the development of China's pharmaceutical industry better and better. Local companies can learn from international companies and learn advanced technology concepts. And management experience.
November will be a busy, full and lively month for pharmaceutical colleagues. I believe that through the three industry exhibitions, pharmaceutical colleagues can gain a lot, and they can be more clear about the future development of the industry, as well as the positioning of enterprises and product development. .
Personal Protective Equipment,hooded coverall with shoecover,hydrogel undereye patch
Shandong Zhushi Pharmaceutical Group Co.,LTD , https://www.sdzs-medical.com